-
Demand for high-end healthcare facilities remains strong; however, the company’s valuation appears demanding
-
Medanta has strong capabilities to leverage its brand image. However, near-term growth looks limited
-
The company's board, in its meeting held on Monday, has approved the purchase of 3 acres of land from Assam Electricity Grid Corporation Ltd for Rs 30 crore plus incidental expenses for registration and possession of the land, the healthcare provider said in a regulatory filing.
-
Encouraged by the demand-supply gap in healthcare needs in the hinterland, the company continues to add bed capacities
-
It is a play on the growing importance of regional health hubs in the northern and eastern states.
-
Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.
-
The Maharashtra Housing and Area Development Authority had set a reserve price of Rs 67.5 crore for the plot in Oshiwara
-
Medanta has strong capabilities to leverage its brand image and win the underserved and growing markets.
-
Even though long-term growth prospects remain intact for Global Health, slow near-term margin expansion due to consistent capex, along with the pricey valuations of the stock has triggered a selloff in the counter.
-
Anand Rathi predicts private hospitals will dominate India's healthcare system as government funding falls short. It recommends buy on Max Healthcare, Rainbow Children’s Medicare, KIMS and Jupiter Life Line Hospitals,
-
What makes this IPO interesting is that eastern India has the lowest concentration of medical specialists among all the regions in India. Further, the company‘s key market, Kolkata, has the lowest bed density across Tier 1 cities.
-
Temasek invested about Rs 700 crore in January 2015 to acquire almost 18% stake in the hospital chain
-
Medanta has a solid footing in the NCR region and is focused on widening its reach in the underserved Tier II markets
-
With this, Trehan, 77, has become India’s richest professional manager with his net worth surging past Rs 8,402.30 crore or $1 billion.
-
Medanta Q2 earnings: The hospital operator's revenue for the quarter came in at Rs 844 crore, reflecting a 24 percent rise YoY from Rs 679 crore
-
"The company's growth momentum will be led by higher volume of patients being treated at new hospitals, scale-up in international patient flow, and improvement in the average revenue per occupied bed backed by superior payor mix/case mix," Motilal Oswal Financial Services said.
-
Medanta is cementing its footprint in north India. Its aggressive expansion plans reflect the growing demand and the opportunities for high-end healthcare facilities in the country
-
Jefferies anticipates the ramp-up of capacity in Lucknow to aid strong revenue and margin traction for Medanta operator Global Health
-
Most brokerages anticipate that the trend of capacity expansion will persist throughout the sector. Investor attention will remain focused on management commentaries for insights into plans to expand capacity, as well as the potential impact of this on profitability and margins.
-
The former AIIMS director said the coronavirus would continue to mutate and become more infectious, and that the country will continue to see smaller waves in the coming months.
-
Despite near-term jitters, hospital operators are undertaking massive capex, not just to expand their offerings but also to add more beds and improve occupancy.
-
The IPO was subscribed 9.58 times during November 3-7
-
A major portion of the IPO was an offer for sale by existing investors and subscription numbers were lower than expected.
-
The IPO has a fresh issue of up to Rs 500 crore and an offer for sale of up to 5,07,61,000 equity shares.
-
Marquee investors participated in the offer included the Government of Singapore, Monetary Authority of Singapore, Nomura Trust, Stichting Depositary APG Emerging Markets Equity Pool, Ontario Teachers' Pension Plan Board, Polar Capital Funds Plc, Government Pension Fund Global, Cohesion MK Best Ideas, and Affin Hwang INR Flexi Fund.
